1. Home
  2. ETON vs VLN Comparison

ETON vs VLN Comparison

Compare ETON & VLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
    SELLHOLDBUYas of 2 days ago
  • VLN
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • ETON 2017
  • VLN 2006
  • Country
  • ETON United States
  • VLN Israel
  • Employees
  • ETON N/A
  • VLN N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • VLN Semiconductors
  • Sector
  • ETON Health Care
  • VLN Technology
  • Exchange
  • ETON Nasdaq
  • VLN Nasdaq
  • Market Cap
  • ETON 199.5M
  • VLN 208.5M
  • IPO Year
  • ETON 2018
  • VLN N/A
  • Fundamental
  • Price
  • ETON $12.58
  • VLN $1.84
  • Analyst Decision
  • ETON Strong Buy
  • VLN Strong Buy
  • Analyst Count
  • ETON 2
  • VLN 1
  • Target Price
  • ETON $15.00
  • VLN $4.00
  • AVG Volume (30 Days)
  • ETON 235.4K
  • VLN 807.9K
  • Earning Date
  • ETON 11-12-2024
  • VLN 11-06-2024
  • Dividend Yield
  • ETON N/A
  • VLN N/A
  • EPS Growth
  • ETON N/A
  • VLN N/A
  • EPS
  • ETON N/A
  • VLN N/A
  • Revenue
  • ETON $34,677,000.00
  • VLN $63,134,000.00
  • Revenue This Year
  • ETON $23.05
  • VLN N/A
  • Revenue Next Year
  • ETON $81.27
  • VLN $28.20
  • P/E Ratio
  • ETON N/A
  • VLN N/A
  • Revenue Growth
  • ETON 5.64
  • VLN N/A
  • 52 Week Low
  • ETON $3.03
  • VLN $1.67
  • 52 Week High
  • ETON $13.98
  • VLN $3.39
  • Technical
  • Relative Strength Index (RSI)
  • ETON 61.05
  • VLN 40.01
  • Support Level
  • ETON $11.80
  • VLN $1.99
  • Resistance Level
  • ETON $13.01
  • VLN $2.29
  • Average True Range (ATR)
  • ETON 0.70
  • VLN 0.18
  • MACD
  • ETON -0.14
  • VLN -0.03
  • Stochastic Oscillator
  • ETON 68.46
  • VLN 2.36

Stock Price Comparison Chart: ETON vs VLN

ETON
VLN
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober01234567891011121314ETON VS VLN

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Audio-Video, which includes the company's HDBaseT solutions for the Audio-Video market deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use